We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about male urethral cancer, a rare condition affecting the tube that carries urine. Understand its symptoms, risk factors, diagnosis, and treatment options.

What is Male Urethral Cancer? Urethral cancer is a rare but serious condition that affects the urethra, the tube responsible for carrying urine from the bladder out of the body. In men, this tube passes through the prostate gland and the penis. When abnormal cells in the urethra begin to grow uncontrollably, they can form a tumor, leading to urethral cancer. This type of cancer can spread rapidly to other parts of the body, and unfortunately, it is often diagnosed at a later stage due to the lack of early, noticeable symptoms. Symptoms of Male Urethral Cancer The early stages of urethral cancer in men may not present any obvious symptoms. However, as the condition progresses, several signs may emerge. It is crucial to remember that these symptoms can also be indicative of other, less serious conditions, but any persistent or concerning changes should be evaluated by a healthcare professional. Common Symptoms Include: Difficulty Urinating: This can manifest as trouble starting the urine flow, an interrupted stream, or a feeling of incomplete bladder emptying. Loss of Urinary Control: Incontinence or a reduced ability to control when you urinate can be a sign. Increased Urination Frequency: Urinating more often than usual, especially at night (nocturia), may occur. Discharge or Bleeding from the Urethra: Any unusual discharge or bleeding from the tip of the penis should be investigated. Lump or Swelling: A palpable lump or swelling in the groin area, on the penis, or in the perineum (the region between the genitals and the anus) can be a symptom. If you experience any of these symptoms, it is essential to consult a doctor for a proper diagnosis and to rule out other potential causes. Causes and Risk Factors for Male Urethral Cancer While there isn't one single definitive cause for urethral cancer, several factors are known to increase a man's risk of developing this condition. Understanding these risk factors can help in early detection and prevention strategies. Known Risk Factors: Frequent Urinary Tract Infections (UTIs): Chronic or recurrent UTIs can irritate the urethra and may increase the risk. History of Sexually Transmitted Infections (STIs): Certain STIs, particularly those causing inflammation or lesions in the genital area, could be linked. Chronic Inflammation of the Urethra (Urethritis): Long-term inflammation can create an environment conducive to cancerous changes. Phimosis: This is a condition where the foreskin of the penis cannot be retracted. It can lead to poor hygiene and increased risk of infection. Exposure to Certain Chemicals: Occupational exposure to specific chemicals, such as those found in dyes or pesticides, has been suggested as a potential risk factor. Age: Like many cancers, the risk of urethral cancer increases with age, particularly after 50. Human Papillomavirus (HPV) Infection: Certain strains of HPV are linked to various cancers, including potentially urethral cancer. History of Bladder Cancer: Men who have had bladder cancer may have an increased risk of developing urethral cancer. It's important to note that having one or more risk factors does not guarantee that you will develop urethral cancer. Conversely, some individuals may develop the condition without any identifiable risk factors. Diagnosis of Male Urethral Cancer Diagnosing urethral cancer can be challenging due to its rarity and the often non-specific nature of its symptoms. There is no routine screening test available for urethral cancer. Therefore, if you experience any symptoms suggestive of the condition, seeking prompt medical attention is vital. Diagnostic Procedures May Include: Physical Examination: A doctor will perform a thorough physical examination, including the genital area and rectum, looking for any abnormalities. Urine and Blood Tests: These tests can help detect abnormal cells or other indicators of infection or disease. Imaging Tests: CT Scan: This provides detailed cross-sectional images of the pelvis and abdomen, helping to assess the extent of the tumor and its spread. Cystoscopy/Ureteroscopy: A thin, flexible tube with a camera (cystoscope or ureteroscope) is inserted into the urethra to visualize the lining and identify any suspicious areas. This procedure allows doctors to look inside the bladder, ureters, and renal pelvis. Biopsy: If suspicious tissue is found during imaging or cystoscopy, a biopsy is performed. A small sample of tissue is removed and examined under a microscope by a pathologist to confirm the presence and type of cancer. Early and accurate diagnosis is critical for effective treatment and improving patient outcomes. Treatment Options for Male Urethral Cancer The treatment approach for male urethral cancer depends heavily on the stage of the cancer, its location, and whether it has spread to other parts of the body. Surgery is often the primary form of treatment. Surgical Interventions: Tumor Excision: In some cases, the tumor may be surgically removed on its own, especially if it is small and localized. Radical Surgery: For more advanced cases, extensive surgery may be required. This could involve removing parts of the urethra, the bladder, or even the entire penis (penectomy). Reconstructive Surgery: If significant parts of the urinary tract are removed, reconstructive surgery may be performed to create new pathways for urine storage and elimination. This might involve creating a stoma for urine diversion or constructing a new urethra. Other Treatment Modalities: Radiation Therapy: This uses high-energy rays to kill cancer cells. It can be delivered externally (using a machine outside the body) or internally (brachytherapy, where radioactive sources are placed directly into or near the tumor). Chemotherapy: This involves using drugs to kill cancer cells. Chemotherapy can
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026